Business Context and Reporting Period
This Form 8-K filing by Bionano Genomics, Inc. (BNGO) reports a corporate governance event. The report date is December 5, 2019, with the event effective December 12, 2019.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel changes and does not contain financial statements.
Material Changes
The material change reported is the resignation of Quan Zhou from the Company's Board of Directors. The filing explicitly states that Mr. Zhou's resignation is not the result of any disagreement with the Company.
Guidance, Outlook, and Risks
The filing contains no guidance, outlook, management commentary on operations, or discussion of risks and contingencies beyond the specific departure of the director.
Key Facts for Investor Verification
- Quan Zhou resigned from the Board of Directors effective December 12, 2019.
- The resignation was voluntary and not due to any disagreement with the Company.
- The filing was signed by R. Erik Holmlin, Ph.D., President and Chief Executive Officer.